| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.09 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.27 | 0.1 |